For the first time, anti-DSG2-abs were also assessed in myocarditis/DCM patients, which tested positive in 48% of cases; moreover, the anti-DSG2-ab titer was similar between ARVC and myocarditis/DCM patients. This evidence concerns the gene DSG2 and myocarditis.